NCT04287946View on ClinicalTrials.gov

Endovascular GSN Ablation in Subjects With HFpEF

NAEnrolling by invitationINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

June 30, 2024

Study Completion Date

November 30, 2024

Conditions
Heart Failure With Preserved Ejection Fraction
Interventions
DEVICE

Ablation

Ablation of a single-side of the greater splanchnic nerve

Trial Locations (3)

Unknown

Nemocnice Na Homolce, Prague

Tbilisi Heart and Vascular Clinic, Tbilisi

Tbilisi Heart Center, Tbilisi

Sponsors
All Listed Sponsors
lead

Axon Therapies, Inc.

INDUSTRY

NCT04287946 - Endovascular GSN Ablation in Subjects With HFpEF | Biotech Hunter | Biotech Hunter